Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Striatin is a scaffolding protein and regulatory B''' subunit of protein phosphatase 2A (PP2A), with no intrinsic enzymatic activity[1][2][5]. It is a core component of the striatin-interacting phosphatase and kinase (STRIPAK) signaling complex, where it coordinates diverse protein assemblies involved in a broad range of cellular functions including cell–cell adhesion, polarity, migration, and the control of apoptosis and cell cycle progression[1][2][3][4]. Striatin interacts with proteins such as calmodulin, various kinases (notably members of the sterile 20/Mst family), and structural proteins, and it shapes the specificity of PP2A activity through its scaffolding role[2][3][4]. STRIPAK complexes containing striatin have been implicated in neurological, cardiovascular, and metabolic diseases but striatin itself is not currently a direct therapeutic target[1][2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Striatin (STRN).